Ascelia Pharma AB (publ) (ACE) — Working Capital to Net Assets Ratio

Latest as of September 2025: 49.3%

Ascelia Pharma AB (publ) (ACE) has a Working Capital to Net Assets ratio of 49.3% as of September 2025. Working capital of Skr56.45 Million (current assets of Skr78.18 Million minus current liabilities of Skr21.73 Million) is measured against net assets of Skr114.40 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Ascelia Pharma AB (publ) (ACE) balance sheet quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

49.3%
Working Capital / Net Assets

Working Capital

Skr56.45 Million
SEK

Current Assets

Skr78.18 Million
SEK

Current Liabilities

Skr21.73 Million
SEK

Ascelia Pharma AB (publ) Working Capital to Net Assets (2016–2024)

This chart shows how Ascelia Pharma AB (publ)'s Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 49.3%, reflecting working capital of Skr56.45 Million against net assets of Skr114.40 Million SEK. Check ACE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Ascelia Pharma AB (publ) (2016–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for Ascelia Pharma AB (publ) from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Ascelia Pharma AB (publ) (ACE) market capitalisation.

Year WC/NA Ratio Working Capital (SEK) Net Assets Current Assets Current Liabilities Change (pp)
2024 27.5% Skr21.74 Million Skr78.94 Million Skr83.72 Million Skr61.98 Million ▲ +5.5 pp
2023 22.0% Skr16.37 Million Skr74.33 Million Skr28.94 Million Skr12.57 Million ▼ -46.2 pp
2022 68.2% Skr123.35 Million Skr180.86 Million Skr160.87 Million Skr37.52 Million ▼ -12.8 pp
2021 81.1% Skr249.50 Million Skr307.83 Million Skr274.61 Million Skr25.11 Million ▲ +5.7 pp
2020 75.4% Skr177.96 Million Skr236.06 Million Skr196.32 Million Skr18.36 Million ▼ -0.5 pp
2019 75.9% Skr179.88 Million Skr237.06 Million Skr192.95 Million Skr13.07 Million ▼ -3.4 pp
2018 79.3% Skr218.88 Million Skr276.07 Million Skr230.08 Million Skr11.20 Million ▲ +30.4 pp
2017 48.9% Skr54.66 Million Skr111.73 Million Skr59.08 Million Skr4.42 Million ▲ +22.5 pp
2016 26.4% Skr20.50 Million Skr77.60 Million Skr23.29 Million Skr2.79 Million
pp = percentage points